CRCM
PFE icon

Corbett Road Capital Management’s Pfizer PFE Stock Holding History

Corbett Road Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-834
Closed -$29K – 126
2020
Q3 		$29K Hold
834
– – 0.03% 115
2020
Q2 		$25K Buy
+834
New +$28.3K 0.02% 111

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Corbett Road Capital Management's PFE Position: Q4 2020 in Review

Corbett Road Capital Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 834 shares — an estimated $29K sold.

Corbett Road Capital Management first reported a position in PFE in Q2 2020 and held it in 2 quarters. The position peaked at $29K in Q3 2020. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Corbett Road Capital Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Corbett Road Capital Management sold 834 Pfizer shares in Q4 2020, an estimated $29K.
  • Corbett Road Capital Management first reported a position in Pfizer in Q2 2020 and held it in 2 quarters.
  • Corbett Road Capital Management's Pfizer position peaked at $29K in Q3 2020.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Corbett Road Capital Management's 13F filing for Q4 2020, filed 5 Feb 2021.